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Introduction to DNP Practice Inquiry Project Report

Kara A. Willett BSN, RN, CCRN

University of Kentucky
College of Nursing
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Central venous catheters (CVC) are vital in present-day medical practice, particularly in
the intensive care unit (ICU). However, their use puts patients at risk for developing central lineassociated bloodstream infections (CLABSIs). Forty-eight percent of ICU patients have central
lines, accounting for about 15 million central-line-catheter-days per year (Institute for Healthcare
Improvement [IHI], 2012). Central line-associated blood stream infections are one of the
deadliest types of hospital acquired infections (HAIs) with a mortality rate near 18%, and are the
sources of considerable morbidity and health care costs (CDC, 2011; Burke, 2003; Glance,
Stone, Mukamel, & Dick, 2011). CLABSIs require additional treatments that impose substantial
economic consequences. The downstream effects of these infections include extended illness,
loss of wages, and the intangible costs related to a reduced quality of life. These bloodstream
infections prolong hospitalization by a mean of seven days, and the estimated attributable cost
per infection is between $3,700 and $39,000 (Institute for Healthcare Improvement, 2012).The
overall direct medical costs of HAIs, (including CLABSI) in hospitals in the United States range
from 28.4 to 33.8 billion dollars annually (Klevens et al., 2007).
The Association for Professionals in Infection Control and Epidemiology (APIC)
promotes a culture of zero tolerance for HAIs (APIC, 2012). The Institute for Healthcare
Improvement (IHI) has described care bundles, or groups of best practices with respect to a
disease process, that when used together result in superior patient outcomes. Research
demonstrates that ICUs which have implemented multiple preventive interventions, including
central line bundles, have nearly eliminated CLABIs (Behrenholtz et al., 2004). However,
sustained reduction of CLABSIs remains intangible in many institutions despite increased
awareness of evidence-based preventive strategies, publication of successful hospital CLABSI
elimination programs, and elimination of reimbursement for the cost of treating CLABSIs
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(Agency for Healthcare Research and Quality, 2010; IHI, 2012; The Society of Healthcare
Epidemiology of America; 2014).
The key to achieving sustainable CLABSI reduction is to combine adaptive cultural
changes with evidence-based practices. The Joint Commission requires hospitals to conduct
periodic risk assessments, measure CLABSI rates, monitor compliance with best practices,
evaluate effectiveness of prevention efforts, provide rate data and outcome measures to key
stakeholders, evaluate all CVCs routinely, and remove nonessential catheters (The Joint
Commission, 2014). This practice inquiry project is an evaluation of provider adherence to an
evidence-based CLABSI prevention guideline utilizing daily chlorhexidine gluconate patient
bathing. The evaluation of provider guideline adherence will provide insight and guide future
quality improvement initiatives in the prevention of CLABSIs. This practice inquiry project
includes three manuscripts, each of which discusses relevant aspects of CLABSIs prevention
utilizing daily whole body chlorhexidine gluconate bathing.
• Manuscript one is an evidence review of the literature to (i) determine the potential
impact of iatrogenic blood loss on the development of anemia, and (ii) to evaluate the
effectiveness of available blood conservation devices and strategies in decreasing
iatrogenic anemia and blood transfusions in adult ICU patients.
• Manuscript two is a cost-analysis of the potential financial benefits of implementing daily
whole body patient bathing with 2% Chlorhexidine Gluconate impregnated cloths in a large
university level-1 trauma center .
• Manuscript three describes the development, implementation, and evaluation of a
blood conservation education intervention, and its impact on nursing knowledge and
attitudes towards future implementation of blood conservation practices.
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Manuscript 1

Chlorhexidine Gluconate Bathing an Adjunct Therapy in Reducing Central Line Associated
Blood Stream Infections: A Literature Review

Kara A. Willett BSN, RN, CCRN
University of Kentucky
College of Nursing
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Abstract
The complexity of the healthcare system is increasing, and the moral duty to provide
quality patient care is threatened by the sky rocketing cost of healthcare. A major concern for
both patients and the hospital’s economic bottom line are hospital-acquired infections (HAIs),
including central line associated blood stream infections (CLABSIs). These often serious
infections result in significantly increased patient morbidity, mortality, length of stay, and use of
health care resources. Historically, most infection prevention and control measures have focused
on aseptic technique of health care providers and in managing the environment. Emerging
evidence for the role of host decontamination in preventing HAIs is shifting the paradigm and
paving a new path for novel infection prevention interventions. Chlorhexidine gluconate has a
long-standing track record of being a safe and effective product with broad antiseptic activity,
and little evidence of emerging resistance. As the attention is directed toward control and
prevention of HAIs, chlorhexidine-containing products may prove to be a vital tool in infection
control. Increasing rates of multidrug-resistant organisms (MDROs), including methicillinresistant Staphylococcus aureus (MRSA), Acinetobacter baumanniic and vancomycin-resistant
Enterococcus (VRE) demand that evidence-based research drive all interventions to prevent
transmission of these organisms and the development of HAIs. This review of literature
examines current evidence related to daily chlorhexidine gluconate bathing and its impact on
CLABSI rates in the adult critically ill patient population.
Keywords: daily chlorhexidine gluconate bathing, central line associated bloodstream
infections (CLABSI), methicillin-resistant Staphylococcus aureus (MRSA), Vancomycinresistant Enterococcus (VRE) or Acinetobacter baumanniic skin colonization acquisition
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Chlorhexidine Gluconate Bathing an Adjunct Therapy in Reducing Central Line Associated
Blood Stream Infections: A Literature Review
An estimated 1.7 million hospital-associated infections (HAIs) occur in United States
hospitals annually, resulting in approximately 100,000 deaths and a cost of up to $45 billion
(Klevens, 2007; Scott, 2009; Umscheid et al., 2011). According to the Center for Disease
Control and Prevention (CDC; 2011a), HAI’s are the most common adverse events encountered
by hospitalized patients, with estimates of one out of twenty patients affected. Forty-eight
percent of intensive care unit (ICU) patients have central venous lines, accounting for about 15
million central venous catheter days per year (Institute for Healthcare Improvement, 2012).
Central line associated blood stream infections (CLABSIs) are one of the deadliest types of HAI
with a mortality rate near 18%, and are the source of considerable morbidity and increased health
care costs (CDC, 2011; Burke, 2003; Glance et al., 2011). The CDC (2011a) defines a CLABSI
as a hospital-acquired infection where a primary bloodstream infection develops in a patient who
had documented presence of a central venous line at the time of infection or within the preceding
48 hours. The infection cannot be related to any other infectious process and cannot be present or
incubating upon patient hospital admission.
Historically, most infection prevention and control measures have focused on aseptic
technique of healthcare providers and in the management of environment (Agency for
Healthcare Research and Quality, 2010). Central line associated bloodstream infection

prevention attempts have included using evidence-based practices at the time of central venous
line insertion, along with novel strategies including antibiotic or antiseptic-coated catheters and
antiseptic dressings. The recent shift towards evidence-based practice has many healthcare
organizations adopting new practices that are aimed at improving patient outcomes and
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decreasing healthcare costs. The CDC (2011b) reported major reductions in CLABSI rates in the
U.S. ICUs from 2001 to 2009; this was based upon data submitted to the CDC’s National
Healthcare Safety Network (NHSN) from healthcare institutions nationwide. An estimated
43,000 CLABSIs occurred among U.S. ICU patients in 2001, compared with 18,000 in 2009, a
58% reduction (Srinivasan, 2011). Due to the significant reduction in CLABSI rates, the
implementation of various prevention initiatives has fostered the idea that CLABSIs are largely
preventable, and that a CLABSI rate of zero is an achievable goal.
The recent increase in multi-drug resistant organisms (MDRO) intensifies the scrutiny for
CLABSI prevention practices. Infections caused by multi-drug resistant organisms, such as
methicillin-resistant Staphylococcus aureus (MRSA), multi-drug resistant Acinetobacter
baumannii, and vancomycin-resistant Enterococcus (VRE), limit the number of effective
antibiotics available for treatment, prolong hospital lengths of stay and increase cost, patient
morbidity and mortality. The idea that these infections may be preventable has spurred interest in
the development of novel strategies and adjunct therapies to reduce infection rates. A major
mechanism underlying the development of a CLABSI particularly with short-term devices in
place for ten days or fewer, is the extra-luminal route, where skin microorganisms invade the
percutaneous tract (Sadfar & Malki, 2004). One intervnetion strategy is daily whole body patient
bathing with chlorhexidine gluconate (CHG). Chlorhexidine gluconate a topical antiseptic has
been used as decolonization therapy to control cross infections (Wendt, et al., 2007). It also has
broad-spectrum antimicrobial effects and has been used to disinfect the skin for surgical
procedures and intravascular catheter insertion (Milstone et al., 2008). Chlorhexidine gluconate
has an excellent safety profile and proven efficacy over a wide spectrum of gram-positive and
gram-negative bacteria, as well as fungi and some viruses (Lin & Hayden, 2010). Unlike many
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other antiseptics, CHG has residual antibacterial activity, which may reduce the microbial
colonization of the patient’s skin and prevent secondary environmental contamination (Milstone,
Passaretti, & Perl, 2008).
Research indicates that daily bathing with two percent CHG-impregnated cloths
decreases patient bacterial skin colonization, healthcare workers’ hand contamination, and
environmental surface contamination (Vernon et al., 2006). Daily cleansing of ICU patients’ skin
with CHG has been associated with reduced incidence of colonization’s with VRE,
MRSA(Climo et al., 2009; Vernon et al., 2006), and multi-drug resistant Acinetobacter
baumannii (Borer et al. 2007; Evans et al. 2010) and has been linked with decreased incidence of
CLABSIs due to VRE and MDR Acinetobacter baumannii (Bleasdale et al., 2007; Borer et al.,
2007; Popovich et al., 2009).
Research Question (PICO)
The development of a well-framed and defined research question is the foundation to
conducting quality research (Stern, C., Zoe, J. & McArthur A., 2014). Using a defined
PICO question will lead to an appropriate study design and methodology, and is an essential part
of the evidence review process. The formation of a PICO question is the first step in the evidence
based practice process and includes the following components: (a) patient population; (b)
intervention or area of interest; (c) comparison intervention or comparison group; and (d)
outcomes. The following PICO question will serve as a guide for extracting the best evidence
from current literature and facilitate evidence-based practice (Fineout-Overholt, Melnyk, &
Schultz, 2005).
Does daily whole body patient bathing using chlorhexidne gluconate in the critically ill
adult population impact central line associated blood stream infection (CLABSI) rates compared
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to traditional daily soap and water bathing?
Methods
Using a predefined strategy to identify the most current and relevant research
articles from the literature, a comprehensive search of the Cumulative Index of
Nursing and Allied Health Literature (CINAHL), Medical Literature Analysis and Retrieval
System Online (MEDline), and PubMed databases was conducted using various
combinations of the following key words: central line associated blood stream infections
(CLABSIs); chlorhexidine gluconate, daily bathing, methicillin-resistant Staphylococcus aureus
(MRSA), Vancomycin-resistant Enterococcus (VRE) or Acinetobacter baumanniic colonization/
acquisition used. Along with these searches, a manual review of reference lists was completed on
the relevant published articles.
The goal of this review was to identify published clinical research to determine
the potential impact of daily CHG whole body patient bathing on the prevention of CLABSIs.
Inclusion criteria were as follows: full-text, peer reviewed nursing or medical journal articles
published in English after the year 2000. Articles involving the study of critically ill human
subjects 18 years of age or older were included in this review. Articles that dealt with
decolonization strategies other than CHG bathing were excluded. Article titles and abstracts were
sorted and literature relevant to the topic of daily whole body chlorhexidine bathing in the adult
critically ill patient population was evaluated. The database search ultimately resulted in the
selection of eight research articles (see Table 1).
Summary of Findings
The eight articles reviewed included one randomized control trial, one non-randomized
clinical trial, one observational cohort with historical controls and five quasi-experimental
15

designs. The study settings were in a variety of critical care specialty areas, both medical and
surgical. Hospital sizes ranged from community medical centers to large tertiary level one
trauma centers. All studies evaluated the impact of using 2% CHG impregnated non-rinse cloths
with the traditional soap-and-water bath basin technique. All but one out of the eight studies
found a statistically significant reduction in CLABSIs with the introduction of CHG daily patient
bathing.
A clinical trial of 836 patients using concurrent controls and a crossover design
investigated whether CHG cleansing would decrease the incidence of primary blood stream
infections (BSIs) compared with traditional soap and water baths in two medical ICUs
(Bleasdale et al., 2007). Patients in the CHG arm were 61% less likely to acquire a primary BSI.
Patients receiving the CHG bathing intervention compared to the traditional soap and water
bathing were at a significantly lower risk of developing a CLABSI (6.4 vs. 16.8 BSIs per 100
central line-days; P=.01). Montecalvo et al. (2012) conducted a prospective, 3-phase study in
both medical and surgical ICUs in four community hospitals totally 21,022 central venous
catheter days. Pre-intervention (phase 1) patients were bathed with soap and water; intervention
(phase 2) patients were bathed with two percent CHG impregnated cloths; post-intervention
(phase 3) CHG bathing was continued but without oversight by research personnel. Study
analysis included CLABSI rates compared over study periods using Poisson regression.
Compared with pre-intervention, during active intervention there were significantly fewer
CLABSIs (6.4 vs. 2.6 per 1000 central venous catheter days, relative risk; P<.001), and this
reduction was sustained during post-intervention (2.9 per 1000 central venous catheter days;
relative risk; P<.001).
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Popovich et al. (2009, 2010) conducted two quasi-experimental studies, one in a medical
population and the other in a surgical population. Popovich et al. (2009) evaluated the use of 2%
impregnated CHG cloths versus soap and water for daily bathing in 318 patients in a 21-bed
MICU at Rush University. The results showed a significant decrease in CLABSI rates (from 5.31
to 0.69 cases per 1,000 central line days; P= .006), along with blood culture contaminations, but
no significant change in rates of secondary blood stream infections, ventilator associated
pneumonia, or urinary tract infections. Popovich et al. (2010) used a surgical ICU setting to test
the use of daily CHG bathing versus traditional soap and water. In a sample of 254 patients
results showed no significant difference in the CLABSI rate between soap-and-water and CHG
bathing periods (3.81 to 4.6 per 1,000 central line days; p = 0.57). However, blood culture
contamination significantly decreased, suggesting that the microbial burden on the skin was
reduced. The authors addressed this finding by pointing out that surgical ICU patients more often
have large, open abdominal wounds. These serve as a source for healthcare worker
contaminations and translocation of bacteria into the bloodstream, causing possible
misidentification of positive blood cultures as CLABSIs.
Evans et al. (2010) demonstrated that bathing trauma patients in the ICU with 2% CHG
impregnated cloths versus soap and water decreased rate of colonization of MRSA and
Acinetobacter baumannii, significantly lowered rates of CLABSIs, and MRSA ventilator
associated pneumonia versus the soap and water group in 539 patients. The patients receiving the
CHG daily bathing intervention demonstrated a significantly lower risk in developing a CLABSI
from the control group (2.1 vs. 8.4 infections per 1000 catheter days; P=0.01). An observational
cohort study design using historical controls at a Level I trauma center evaluated effectiveness of
a quality improvement intervention protocol implementing daily cleansing with CHG cloths
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versus soap and water in144 patients. The results included a CLABSI rate reduction of 73.7%
(12.07 to 3.17 CLABSIs per 1000 central line-days; P=.0358; Dixon & Carver, 2010). Another
quality improvement initiative utilizing daily CHG bathing versus soap and water in efforts to
reduce CLABSI rates was conducted at Emory University Hospital (Holder & Zellinger, 2009).
A six-month before and after design was used; CLABSI rates decreased from 1.6 to 0.73 in the
cardiovascular ICU, from 4.39 to 0.83 in one medical ICU, and from 2.35 to 0.78 in the second
medical ICU. Overall both the CLABSI reduction rate and MRSA/VRE colonization incidence
decreased from 3.6 to 1 per 1,000 patient days upon initiation of daily CHG patient bathing.
A large multicenter, cluster-randomized, non-blinded crossover trial of 7,727 patients
investigated

the effect of daily bathing with CHG impregnated cloths versus soap and water on

the acquisition of MDROs and the incidence of hospital-acquired bloodstream infections (Climo
et al., 2013). Overall the rate of MDRO acquisition decreased 23% between intervention and
control group (5.10 versus 6.60 cases per 1000 patient –days; P=.03) and rate of hospitalacquired bloodstream infection reduction of 28% (4.78 vs. 6.60 cases per 1000 patient-days;
P=0.007).The analysis showed a 53% reduction (1.55 vs. 3.30 cases per 1000 catheter-days,
P0.004) in CLABSI rates between the intervention and control (Climo et al., 2013). In this
multicenter study consisting of various medical and surgical ICUs a secondary analysis
examined whether the reductions in bloodstream infection rates were related to the type of unit.
There were no significant variations between the type of unit and the development of
bloodstream infections, suggesting that daily CHG bathing may be beneficial in a range of
settings.
With the use of any medication or solution, the occurrences of adverse reactions or side
effects are major concerns. Four out of the eight studies addressed adverse reactions linked with
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the use of CHG to patient rash, breakdown, or allergic reactions. In Climo et al. (2013), the
overall incidence of skin reactions among patients assigned to CHG bathing group was 2.0% (78
of 3970 patients). All skin reactions were ruled to be unrelated to the bathing interventions, and
overall, 85% of the reactions were classified as mild to moderate. During the study conducted by
Bleasdale et al. (2007) only three out of the three hundred ninety one patients in the CHG arm
developed a skin reaction but all were ultimately attributed to other factors. Evans et al. (2010)
reported only two rashes during the interventions period, both of which were attributed to
antibiotic therapy and resolved without treatment. Chlorhexidine gluconate bathing was
discontinued in three patients because of skin rash and restarted in two of the three patients
without adverse event; the third patient also had thrombocytopenia that resolved with stopping
multiple medications and chlorhexidine (Montecalvo et. al, 2012). In total all reactions were
eventually attributed to other factors and no major adverse reactions were reported.
The routine and frequent use of CHG bathing may raise concerns about promoting the
emergence of CHG resistance organisms. Only two of the eight studies explored the possibility
of CHG resistance. In Bleasdale et al. (2007) no isolates obtained demonstrated significant CHG
resistance. In Climo et al. (2013) no emergence of MRSA or VRE isolates with high-level
resistance were identified. In the remaining reviewed studies, resistance was not addressed. The
potential for the development of resistance to CHG remains a significant concern and should be
examined over time.
Cost Analysis
Although no formal cost analysis was undertaken in any studies reviewed or currently
available in the literature. Some studies address cost, which in the state of today’s economy is
essential for both organizational and patient financial well-being. Climo (2009) identified the use
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of CHG as a low cost solution for infection control. However, this study used CHG solution
mixed in basins, versus the other studies that utilized the CHG impregnated cloths, which would
be basin free. It has also been suggested that bath basins may be a reservoirs of pathogenic
microbes, and the link in transmission of such pathogens (Milstone, Passaretti, & Perl, 2008).
Although, the cost of chlorhexidine cloths is greater than non-chlorhexidine cloths ($5.50 vs
$1.46 per bath), due to the 75% reduction in CLABSIs over a six month period of time, a
projected calculated cost savings of $1.56 million per year was estimated, if CHG baths were
used in all of the study hospital’s ICUs ( Holder & Zellinger, 2009). There was no statistical
difference found in cost between bathing using 2% CHG-impregnated cloths ($7.85 per patient
per day) versus the four percent CHG solution basin bath ($5.22 per patient per day), although a
statistically significant decrease in nursing time to administer the bath was observed with CHGimpregnated cloth (p =0.008; Ritz et al., 2011). Evans et al. (2010) estimated the cost of CHG
impregnated cloths to be $5.52 per bath at the time of the trial as opposed to $1.23 per bath for a
disposable bathing product that does not contain CHG. Dixon and Carver (2010) identified a
$728,820 cost savings using two percent CHG-impregnated cloths versus traditional soap and
water within seventeen months of use. After calculating the difference between the increased
expenditure of switching to CHG impregnated cloth bathing there was an equivalent to a savings
of $945,000, which was more than ten times the cost of chlorhexidine, bathing (Montecalvo et
al., 2012).
Implications for Practice
Poor compliance with hand hygiene, reluctance to adopt barrier precautions owing to
unintended consequences of isolation, and controversy over the cost-effectiveness and feasibility
of legislated universal surveillance have been barriers to effective infection control (Agency for
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Healthcare Research and Quality, 2010). Furthermore, while these methods (when practiced
consistently) may prevent transmission to other patients, they confer little or no protection to the
patient who becomes colonized with the resistant organism. While chlorhexidine bathing should
not be considered a replacement for contact precautions, use of a routine decontaminationbathing regimen can decrease the potential for organism transmission even before results of
surveillance testing are available. Furthermore, in a recent epidemiologic investigation of the
impact of universal active surveillance for MRSA conducted in an academic medical center with
a long history of comprehensive infection-control practices, more than half of MRSA
colonization’s were demonstrated to occur after a negative surveillance culture was confirmed on
admission, suggesting that there is room for potential benefit from daily inpatient
decontamination procedures in addition to the current infection-control efforts (Harbarth, 2008).
Limited but promising studies have demonstrated that daily CHG bathing is an option to
reduce HAIs and bacterial colonization on patients’ skin, especially in patients in the ICU
(Bleasdale et al., 2007; Popovich et al. 2010 ; Holder & Zellinger, 2009; Evans et al. 2010;
Dixon & Carver, 2010; Climo et al., 2013; Montecalvo et. al, 2012). The Healthcare Infection
Control Practices Advisory Committee (HICPAC) of the Centers for Disease Control and
Prevention published revised CLABSI-prevention guidelines in 2011. The 2011 guideline for
prevention of intravascular catheter related infections by the Centers for Disease Control and
Prevention includes a category II recommendation for daily bathing with two percent CHG
(O’Grady et al., 2011).
Implications for Future Research
As CLABSIs and other healthcare-associated blood stream infections are becoming
increasingly more prominent outside the ICU, the use of CHG daily bathing should also be
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examined in the non-ICU setting (Climo et al., 2013). Additional considerations in this
noncritical population should include a careful assessment of adverse effects, such as patient
reports of skin dryness and irritation. A recommendation for further nursing research would
include future studies to evaluate the effectiveness and feasibility of CHG bathing in non-ICU
settings.
Follow up studies are also needed within various ICU settings, including surgical versus
non-surgical, patients receiving immunosuppressant therapy, and invasive equipment, along with
the potential benefits of this intervention on blood-culture contamination rate, use of antibiotic
agents, and mortality. There are several different types of central venous line access devices
including non-tunneled, tunneled, implantable ports, and peripherally inserted central catheters.
An area for future research is to evaluate effectiveness of CHG bathing in the prevention of
CLABSIs based on type of central venous line access device.
A delicate balance must be achieved between the rigorous regulatory oversight inherent
in the traditional research model, and the necessity for innovative quality-improvement
initiatives, such that novel products can be tested in high-risk populations, including children.
Avoiding overuse of CHG in settings where it has not been proven to have benefit may be
especially prudent with the possibility of CHG organism resistance.
Conclusion
Identifying simple, cost-effective, and safe strategies for the prevention of health care–
associated infection is essential. Daily bathing with CHG impregnated cloths is a strategy that is
relatively straightforward to implement and sustain because it does not require a substantial
change from patient-bathing practices that are currently routine. Daily bathing with 2% CHG
impregnated cloths as an adjunct therapy in the prevention of CLABSIs is promising. The
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evidence is strongest for MICU patients; a trial conducted solely in a surgical ICU did not find a
benefit with CHG bathing. The majority of the studies were quasi-experimental, with little to no
assessment of or adjustment for confounding variables. While no formal cost analysis was done, the

low cost of CHG compared with the high cost of even a single CLABSI suggests that CHG
bathing likely saves costs. In conclusion, existing data largely obtained from a single randomized
clinical trial, a non-randomized controlled trial and quasi-experimental designs support the practice of
daily bathing with 2% CHG impregnated cloths for the reductions of CLABSIs.
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Table 1 Summary of reviewed articles

Author

Study Design

Sample/Setting

Purpose

Findings

Bleasdale, S.C., Trick, W.E.,
Gonzalez, I.M., Lyles, R.D.,
Hayden, M.K., & Weinstein,
R.A. (2007). Effectiveness of
chlorhexidine bathing to reduce
catheter-associated bloodstream
infections in medical intensive
care unit patients. Archives
Internal Medicine, 167(19),
2073-2079.
Dixon, J.M., & Carver, R.L.
(2010). Daily chlorhexidine
gluconate bathing with
impregnated cloths results in
statistically significant reduction
in central line-associated
bloodstream infections.
American Journal of Infection
Control, 38 (8), 17-21. doi:
10.1016/j.ajic.2010.06.005

Cross-over
(concurrent
control group)
Clinical Trial

836
patients/MICU

Determine if
patients bathed
daily with 2%
CHG cloths have
a lower
incidence of
primary
bloodstream
infections (BSI)
compared to
those bathed in
soap & water

Patients in the CHG
arm were 61% less
likely to acquire a
primary BSI compared
to soap & water
group. Patients in the
CHG arm were at a
lower risk of CLABSI
(6.4 vs 16.8 BSIs per
1000 central linedays; P=.01)

Observational
Cohort with
Historical
Controls

144
patients/SICU

Evaluate a
quality
improvement
protocol
instituted to
reduce CLABSI
rates with a 3month
effectiveness
study using 2%
CHG cloths for
daily bathing

A decrease in
CLABSI rates from
12.07 per 1000 central
line days to 3.17
CLABSIs per 1000
central line-days
(73.3% rate reduction;
P = .0358)

Climo, M., Yokoe, D., Warren,
D., Perl, T., Bolon, M.,
Herwaldt, L., & Weinsten, R.A.,
Sepkowitz, K.A., Jernigan, J.A.,
Sanogo, K., & Wong, E. (2013).
Effect of daily chlorhexidine
bathing on hospital-acquired
infection. New England Journal
Of Medicine, 368(6), 533-542.
doi:10.1056/NEJMoa1113849

Clusterrandomized,
nonblinded
crossover trial

7727 patients/
MICU, CCU,
SICU, CTICU

Evaluate the
effectiveness of
bathing patient
with 2% CHG
cloths in
reducing the risk
of MDRO
acquisition &
hospital acquired
bloodstream
infections

Evans, H.L., Dellit, T.H., Chan,
J., Nathens, A.B., Maier, R.V., &
Cuschieri, J. (2010). Effect of
chlorhexidine whole-body
bathing on hospital-acquired
infections among trauma
patients, Archives of Surgery,
145(3), 240-246.

Before and
after study

TICU/ 539 total
patients

Determine if
daily bathing
with 2% CHG
cloths would
decrease
colonization &
HAIs of resistant
bacteria in
trauma patients

CLABSIs rates
decreased by 53%
during intervention
period compared to
control (3.61 vs. 5.24
cases per 1000 patient
days, P=0.004).
Overall HAI rates
decreased 28% &
MDRO acquisition
decreased 23% after
CHG bathing.
Pts. receiving CHG
baths were
significantly less
likely to acquire a
CLABSI (2.1 vs 8.4
infections per 1000
catheter-days; P=.01),
incidence of VAP was
not affected by CHG
baths however, pts.
were less likely to
develop MRSA VAP,
Colonization of
MRSA &
Acinetobacter were
significantly lower in
the CHG group than
in the comparison
group
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Author

Study Design

Sample/Setting

Purpose

Findings

Holder C. & Zellinger M. (2009)
Daily bathing with chlorhexidine
in the ICU to prevent central
line-associated bloodstream
infections. Journal of Clinical
Outcomes Management, 16, 509513.

Before and
after study

NR/MICU/
CTICU

Evaluate quality
improvement
initiative to
reduce CLABSI
rates using CHG
wipes for daily
bathing

CLABSI rates
decreased from 3.6 to
1 per 1000 patient
days; Rate of
MRSA/VRE
colonization
decreased from 3.6 to
1 per 1000 patient
days

Montecalvo, M., McKenna, D.,
Yarrish, R., Mack, L., Maguire,
G., Haas, J., DeLorenzo, L.,
Dellarocco, N., Savatteri, B.,
Rosenthal, A., Watson, A.,
Spicehandler, D., Shi, Q.,
Visintainer, P. & Wormser, G.
(2012). Chlorhexidine bathing to
reduce central venous catheterassociated bloodstream infection:
impact and sustainability. The
American Journal Of Medicine,
125(5), 505-511.
doi:10.1016/j.amjmed.2011.10.0
32
Popovich, K.J., Hota, B., Hayes,
R., Weinstein, R.A., & Hayden,
M.K. (2009). Effectiveness of
routine patient cleansing with
chlorhexidine gluconate for
infection prevention in the
medical intensive care unit.
Infection Control and Hospital
Epidemiology, 30(10), 959-963.
doi: 10.1086/605925

Before and
after study

21,022 Central
Venous Catheter
Days/MICU,
SICU

Determine the
impact &
sustainability of
daily patient
bathing with 2%
CHG cloths on
CLABSI rates

CLABSI rates 6.4
versus 2.6 per 1000
central venous
catheter days

Before and
after study

318 patients/
MICU

To examine
effectiveness of
cleansing
patients with 2%
CHG cloths in
reducing rates of
CLABSI

Popovich, K.J., Hota, B., Hayes,
R., Weinstein, R.A., & Hayden,
M.K. (2010). Daily skin
cleansing with chlorhexidine did
not reduce the rate of central-line
associated bloodstream infection
in a surgical intensive care unit.
Intensive Care Medicine, 36(5),
854-858. doi: 10.1007/s00134010-1783-y

Before and
after study

254 patients
/SICU

To evaluate the
effect of daily
2% CHG cloth
bathing on
CLABSI rates

CLABSIs decreased
from (5.31 to 0.69
cases per 1000 central
line days; P=.006)
from soap/water
bathing to CHG
bathing. Additional
outcomes included a
decline in blood
culture contamination
rate in CHG group.
Secondary BSI, CDI,
VAP, & UTI rates did
not change between
CHG & soap/water
groups
No significant
difference in the rates
of CLABSI in the
soap-and-water versus
CHG periods were
noted (4.6 vs. 3.81 per
1,000 central line
days), blood culture
contamination rates
declined significantly

Note. CHG=Chlorhexidine Gluconate; HAI=hospital acquired infections; MRSA= methicillin-resistant
Staphylococcus aureus; VRE= vancomycin-resistant Enterococcus; CVC= Central venous catheter; BSI= blood
stream infection; VAP=ventilator associated pneumonia; UTI; urinary tract infection; MICU=medical intensive care
unit; TICU=trauma intensive care unit; SICU=surgical intensive care unit; CCU=coronary care unit;
CVSICU=cardio vascular surgical intensive care unit, CLABSI= Central line associated blood stream infection
CDI=Clostridium difficile infection, NR=Not Reported
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Abstract
Hospital-acquired infections including central-line associated blood stream infections
(CLABSIs) are a major concern in today’s health care system. CLABSIs are a significant source
of patient mortality, increased length of stay, and healthcare spending. The heightened
awareness of these infections along with their escalating cost has amplified implementation of
preventative protocols. Organizations are continuously reevaluating routine operating
procedures and patient care guidelines to assure the delivery of safe and effective care but also
financially responsible care. The search for CLABSI prevention strategies with a range of
benefits, including improved patient outcomes and an overall cost reductions is critical. The
purpose of this paper is to review a daily bathing protocol utilizing chlorhexidine gluconate
impregnated cloths as a CLABSI reduction technique and to explore potential financial worth of
implementation.
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Quantifying the Value of Daily Bathing with Chlorhexidine Gluconate
Impregnated Cloths
Hospital-associated infections (HAIs) are a significant cause of morbidity, mortality, and
increase in healthcare costs (World Healthcare Organization [WHO], 2014). HAIs affect one out
of every twenty hospitalized patients at any given time (Klevens, 2007). Some of the most
serious HAIs are those that involve the bloodstream. Central-line associated bloodstream
infections (CLABSIs) are the most common cause of health care-associated infection in the
bloodstream (WHO, 2014). Forty-eight percent of intensive care unit (ICU) patients have central
lines, such as broviac and peripherally inserted central lines, accounting for approximately 15
million central venous catheter days per year (Institute for Healthcare Improvement, 2012).
CLABSIs are one of the deadliest types of HAI with a mortality rate near eighteen percent, and
significantly increased healthcare costs (Centers for Disease Control and Prevention [CDC],
2011a; Burke, 2003; Glance et al., 2011). The increased length of hospital stay and risk of
mortality lead to an additional $39,000 per episode of CLABSI (The Society of Healthcare
Epidemiology of America, 2014).
The recent increase in multi-drug resistant organisms (MDROs) intensifies the scrutiny
for CLABSI prevention practices. Infections caused by MDROs, such as methicillin-resistant
Staphylococcus aureus, multi-drug resistant Acinetobacter baumannii, and vancomycin-resistant
Enterococcus, limit the number of effective antibiotics available for treatment. The idea that
these infections may be preventable has spurred interest in the development of novel strategies
and adjunct therapies to reduce infection rates. In the last several years, major changes have
impacted HAI prevention in U.S. healthcare. These developments include improved
interdepartmental coordination of federal efforts aimed at HAI prevention, (US Department of
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Health and Human Services, 2013) posting of hospital-specific HAI rates on public websites to
promote transparency, and linking of hospital specific HAI performance to financial
reimbursement as a strategy to motivate hospitals’ HAI prevention efforts (Centers for Medicare
and Medicaid Services, 2013).
Description of Whole Body Patient Bathing with
Chlorhexidine Gluconate Impregnated Cloths
Research indicates that daily bathing with two percent chlorhexidine gluconate (CHG)impregnated cloths decreases patient bacterial skin colonization, healthcare workers’ hand
contamination, and environmental surface contamination (Vernon et al., 2006). CHG is a topical
antimicrobial agent and a primary ingredient in numerous products including oral rinses, creams,
lotions, foams, gels, sprays, dressings, and ointment forms. CHG has broad-spectrum
antimicrobial effects and is used to disinfect the skin for surgical procedures and intravascular
catheter insertion (Milstone, Passaretti, & Perl, 2008). CHG also has an excellent safety profile
and proven efficacy over a wide spectrum of bacteria, as well as fungi and some viruses (Lin &
Hayden, 2010). Unlike many other antiseptics, CHG has residual antibacterial activity, which
may reduce the microbial colonization of the patient’s skin and prevent secondary environmental
contamination (Milstone, Passaretti, & Perl, 2008).
A CHG bathing protocol (Figure 1) utilizing impregnated cloths would direct nursing
staff to perform whole body bathing; replacing traditional soap and water bathing during
hospitalization. Prepackaged cloths containing two to six large wipes for a full body wash
provide an ideal medium for hospital bathing. Cloths depending on manufacturing labels can be
warmed or used at room temperature. Each cloth is utilized for areas below the jaw line daily;
episodes of incontinence are to be cleaned with non-medicated washcloths and water. Bathing
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with CHG cloths includes firm massage to remove bacteria. Once bathed, a patient skin may feel
sticky momentarily. However, the skin should be allowed to air dry and not rinsed. All lotions,
ointments or emollients must be CHG compatible because some can inactivate the CHG. After
cleansing each body area, device tubing within six inches of the patient should be cleansed
including Foleys, drains, G-tube/J-tubes, rectal tubes, and chest tubes (Agency for Healthcare
Research and Quality, 2013).
Implementation of an Evidence-Based CLABSI Prevention Protocol
Translating evidence into practice requires an integrated approach to address both
mechanical and adaptive workflow, including a thorough understanding of the healthcare
delivery system and human behavior (Pronovost, Berenholtz, & Needham, 2008). Cultural
change and the transformation in behaviors of healthcare workers significantly affect the
reduction in HAIs, as seen in the 2006 Michigan Keystone Project (Pronovost et al., 2006). The
project implemented evidence-based preventive strategies recommended by the CDC along with
focusing on changing provider behavior by creating a culture of safety, incorporating a
centralized education program for team leaders at each institution, and closely collaborating with
infection control personnel. The intervention was extremely successful resulting in a large and
sustained reduction (up to sixty-six percent) in rates of CLABSIs that was maintained throughout
the eighteen-month study period (Pronovost et al., 2006).
A recent document providing guidance for CLABSI prevention implementation identifies
four key principles for strategy implementation: engaging, educating, executing, and evaluating
(Marschall et al., 2014). The engagement of hospital frontline staff and senior leadership is the
first step in the process to implement a CLABSI protocol (Weaver et al., 2014). Identifying and
involving prevention champions can fuel organizational motivation by engaging and stimulating
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peers. Establishing a multidisciplinary team will encourage collaboration and create a culture of
safety with promotion of accountability for prevention of CLABSI. Outcome data will be shared
regularly with individual units. Open communication with frontline staff will be maintained
involving program improvement and sustainability (Marschall et al., 2014). Educational
programs including CLABSIs prevention significance and appropriate bathing technique should
be provided to all healthcare personnel involved in the direct delivery of CHG baths and vary in
delivery method and evolving competencies.
Program implementation will be executed by standardizing the care process to help
increase staff compliance and prevention sustainability. Quality improvement methodologies
will be utilized to structure the prevention effort (Marschall et al., 2014). Process measures will
be evaluated by performing bathing audits and outcomes measures by trending CLABSI rates.
Stakeholders and frontline staff will be provided with frequent program evaluation data. Goals
of improvement and outcomes should be clearly articulated and evaluated with mandatory
competencies (Marschall et al., 2014). Successful implementation requires the ongoing support,
involvement, and shared accountability of hospital leadership, healthcare providers, payers,
legislative leaders, and other members of the healthcare community who together are privileged
with the responsibility for providing patients with safe, high-quality, high-value health care.
Review of Evidence to Support Daily Chlorhexidine Gluconate Bathing
A major mechanism of CLABSIs particularly with short-term devices, in place for ten
days or fewer is the extra-luminal route, where skin microorganisms invade the percutaneous
tract (Sadfar & Malki, 2004). One strategy is daily whole body patient bathing with
chlorhexidine gluconate (CHG). Research indicates that daily bathing with two percent CHGimpregnated cloths decreases patient bacterial skin colonization, healthcare workers hand
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contamination, and environmental surface contamination (Vernon et al., 2006). Daily cleansing
of ICU patients’ skin with CHG has been associated with reduced incidence of colonizations with
vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA;
Climo et al., 2009; Vernon et al., 2006), and multi-drug resistant Acinetobacter baumannii
(Borer et al. 2007; Evans et al. 2010) and has been linked with decreased incidence of CLABSIs
including those due to VRE and MDR A. baumannii (Bleasdale et al., 2007; Borer et al., 2007;
Evans et al., 2010, Popovich et al., 2009).The Healthcare Infection Control Practices Advisory
Committee (HICPAC) of the Centers for Disease Control and Prevention published revised
CLABSI prevention guidelines in 2011 that included a category II recommendation for daily
bathing with two percent CHG (O’Grady et al., 2011).
The Cost-Benefit Analysis of Implementing the CHG Protocol
Although no formal cost-benefit analysis is available in the literature, several studies
evaluated CHG impregnated cloths and CLABSI preventions addressed the financial
implications of using CHG impregnated cloths. The cost of cloths is greater ($5.50 per bath)
compared to the traditional soap and water ($1.46 per bath). However, a projected cost savings
of $1.56 million per year was estimated by reducing CLABSIs by 75 percent over a six month
period when utilized in all ICUs (Holder & Zellinger, 2009). Evans et al. (2010) estimated the
cost of CHG impregnated cloths to be $5.52 per bath at the time of the trial as opposed to $1.23
per bath for a bathing product that did not contain CHG. Dixon and Carver (2010) identified a
$728,820 cost savings by using two percent CHG-impregnated cloths versus traditional soap and
water over seventeen months of use. After calculating the cost difference between switching to
CHG impregnated cloth bathing, there was an equivalent to a savings of $945,000, which was
more than ten times the cost of CHG bathing (Montecalvo et al., 2012). A cost benefit analysis
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for the implementation of a CHG bathing protocol includes staff training, product and CLABSI
cost. Implementation in one hospital unit with 30 nurses and six nursing care assistants, each
obtaining a one-hour in-service at $24/hr for nurses and $12/hr for assistants would total $822.
Using the current market price of CHG impregnated cloths of $8.47 per bath and calculating for
1000 central line days totals $8,470. Total protocol implementation cost would be $9,292. Using
an estimated CLABSI cost of $39,000 if only one incidence of CLABSI is prevented the total
savings is significant at $29,708 (Table 1; The Society of Healthcare Epidemiology of America,
2014).
Another important factor to address when assessing cost is nursing time to deliver CHG
baths which hinges on the delivery method. One study comparing bathing delivery methods
found that the mean time to administer the traditional basin bath was 4.065 minutes, while the
mean time of a CHG impregnated cloths bath was 3.314 minutes (Ritz et al., 2012). This
difference was statistically significant (t = 2.855; P = .008). More time was likely saved when
considering the time needed to gather bath supplies and linen for the traditional basin bath. This
time saved can be better utilized to optimize workflow thus having the potential for cost savings
elsewhere.
Conclusion
Significant financial costs are associated with CLABSIs, in addition to the increased
morbidity and mortality that results from these infections. CLABSI costs include those related to
diagnosis and treatment; prolonged hospital stays, and, more recently, lack of reimbursement by
third-party payers for expenses incurred. The economic consequences of CLABSIs and
implemented prevention strategies can be complex to quantify, as many factors come into play.
Identifying simple, cost-effective, and safe strategies for the prevention of HAIs is essential. The
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cost of providing any intervention merits consideration in a climate of cost containment. Each
institution negotiates prices with their vendors, so costs of the methods may vary. Daily bathing
with two percent CHG impregnated cloths, as an adjunct therapy in the prevention of CLABSIs
is promising for both improved patient outcomes and decreased healthcare costs.
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Figure 1. Example Chlorhexidine Bathing Protocol

Universal ICU Decolonization: An Enhanced Protocol (Agency for Healthcare Research and
Quality, 2013)
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Table 1. Cost Benefit Analysis

Cost Benefit Analysis in One Hospital Unit
CLABSI cost per episode

$39,000**

Chlorhexidine Gluconate 2%
Impregnated cloths
per bath $8.47*

$8,470

X 1000 central line days

Educational In-service
Nurses (30) - $25/hr classroom
time

$750

Educational In-service
Nursing Care Technicians (6) $12.00/hr classroom time

$72

Potential Savings

$39,000
$8,470
$750
$72

$29,708

*price based on current market price per www.sage.com
**The Society of Healthcare Epidemiology of America, 2014
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per hospital unit
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Abstract

Purpose: This practice inquiry project was designed to (i) evaluate adherence to a daily chlorhexidine
gluconate (CHG) bathing guideline and (ii) to identify associations between guideline adherence and
patient characteristics such as age, Injury Severity Score (ISS), Charlson Comorbidity Index score,
location of central line, central line dwell time, and body mass index (BMI).
Setting: This project took place in two 12-bed trauma/surgical intensive care units at the University of
Kentucky Chandler Medical Center, an 875-bed American College of Surgeons accredited level 1 trauma
center located in central Kentucky.
Population: The sample consisted of 100 adult patients admitted with trauma-related diagnoses, Of the
participants, 61 were male and 39 were female. The average age of the study participants was 48.65 years
(SD = 18.7).
Inclusion Criteria: Inclusion criteria were that participants were all adults (18 years or older) with the
documented presence of a central line within 24 hours of admission to the intensive care unit, a diagnosis
related to trauma, and no documented CHG allergy.
Design and Methods: This retrospective descriptive study of electronic medical records data used
simple random sampling to retrieve 100 electronic medical records from the University of Kentucky
Trauma Registrar Database from June 2013 to June 2014.
Results: Patients received a CHG bath 60.5% of the days a central line was present. Further analysis
showed 17% of patients received CHG baths each day a central line was present. Adherence did not vary
significantly based on central line location. Internal jugular lines were washed with CHG 61.3% of days,
subclavian lines were washed with CHG 60.7% of days, and femoral lines were washed with CHG 50.7%
of days. A statistically significant negative correlation was found between central line dwell days and
guideline adherence with a Spearman’s rho = -0.48 and p < 0.0001. However, no evidence of correlation
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between guideline adherence and the following existed: ISS (Spearman’s rho = -0.17; p < 0.091), BMI
(Spearman’s rho = 0.15; p < 0.145), Charlson Comorbidity Score (Spearman’s rho = -0.05; p <0.603), or
age (Spearman’s rho =0.13; p < 0.117). A Kruskal-Wallis Test revealed no statistically significant
difference in guideline adherence across three different central venous catheter locations (χ² [2, n = 93] =
0.293, p = 0.864).
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An Evaluation of Chlorhexidine Gluconate Bathing in Trauma/Surgical Intensive Care Units: A
Retrospective Chart Review
Hospital-acquired infections (HAIs) are infections developed by patients while in the hospital
receiving treatment for another condition (World Health Organization [WHO], 2011). HAIs may be
caused by any infectious agent, including bacteria, fungi, and viruses, as well as other less common types
of pathogens. The Healthcare Infection Control Practices Advisory Committee (HICPAC) of the Centers
for Disease Control and Prevention (CDC) advises a variety of strategies to reduce HAIs. These strategies
include hand hygiene, isolation practices, and meticulous sterile techniques for the placement of catheters
(O’Grady et al., 2011). Central lines are intravascular catheters placed into a large vein in the neck
(internal jugular vein), chest (subclavian vein or axillary vein), or groin (femoral vein). These catheters
are common in the care of hospitalized, critically ill patients, as they provide reliable venous access for
clinical activities such as blood sampling, infusion of medications, and hemodynamic measurement to
inform fluid management decisions. Although clinically useful, central lines are the leading cause of
central line-associated bloodstream infections (CLABSIs) frequently implicated in life-threatening
illnesses (U.S. Department of Health and Human Services, 2011; Klevens et al., 2007).
CLABSIs are the sources of considerable morbidity and healthcare costs (CDC, 2011b; Burke,
2003; Glance, Stone, Mukamel, & Dick, 2011). CLABSIs are one of the deadliest types of HAIs, with a
mortality rate close to 18%. Forty-eight percent of intensive care unit (ICU) patients have central lines.
This accounts for approximately 15 million central line catheter days per year (Institute for Healthcare
Improvement, 2012). In addition, these bloodstream infections prolong hospitalization by a mean of seven
days, thereby increasing the cost of care. The estimated attributable cost per infection is between U.S.
$3,700 and $39,000 (Institute for Healthcare Improvement, 2012). The overall direct medical costs of
HAIs (including CLABSIs) in hospitals in the United States range from $28.4 to $33.8 billion annually
(Klevens et al., 2007).
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A major mechanism of CLABSIs, particularly with short-term devices in place for 10 days or
less, is the extra-luminal route, where skin microorganisms invade the percutaneous tract (CDC, 2011;
Safdar & Malki, 2004). One CLABSI prevention recommendation is bathing the patient’s skin with
chlorhexidine gluconate (CHG), an antiseptic agent that has broad-spectrum activity against many
organisms (Bleasdale et al., 2007; Popovich et al., 2009; Munoz-Price, et al. 2009; Marschall et al., 2014;
Institute for Healthcare Improvement, 2012). Unlike many other antiseptics, CHG has residual
antibacterial activity that may reduce the microbial colonization of patients’ skin and prevent secondary
environmental contamination (Bleasdale et al., 2007; Climo et al., 2009).
Research indicates that daily bathing with CHG decreases patient bacterial skin colonization,
healthcare workers’ hand contamination, and environmental surface contamination (Vernon et al., 2006).
Daily cleansing of ICU patients’ skin with CHG has been associated with the reduced incidence of
colonization with vancomycin-resistant Enterococcus (VRE), methicillin-resistant Staphylococcus aureus
(MRSA);(Climo et al., 2009; Vernon et al., 2006), and multidrug-resistant Acinetobacter baumannii
(Borer et al. 2007; Evans et al. 2010). In possible correspondence, it has also been linked with a decreased
incidence of CLABSIs, including those due to VRE and multidrug-resistant Acinetobacter baumannii
(Bleasdale et al., 2007; Borer et al., 2007; Climo et al., 2009; Evans et al., 2010, Popovich et al., 2009).
As the acuity of patients and the complexity of the healthcare system continue to intensify, patient and
organizational outcomes are becoming more complex (U.S. Department of Health and Human Services,
2011). As a result, it is important that hospitals, administrators, and providers address issues, like
CLABSIs, and find solutions promptly. One vital step in quality assurance is to evaluate adherence to
practice guidelines and policies developed to counteract a healthcare problem. According to the CDC, the
recommended guidelines for the prevention of intravascular catheter-related infections identifies daily
patient bathing with 2% CHG as an adjunct therapy in the prevention of CLABSIs (O’Grady et al., 2011;
Marschall et al., 2014; Institute for Healthcare Improvement, 2012). The current policy at the University
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of Kentucky Chandler Medical Center is that all patients over the age of one month, with a central line
present, are to be bathed daily using a CHG solution (University of Kentucky Hospital, 2013).
No current literature identifies associations between daily CHG bathing guideline adherence and
patient characteristics. However, literature does identify patient characteristics and factors that increase
patients CLABSI risk, mortality, and impact nursing process, which when compounded may influence
nursing adherence to daily CHG bathing for CLABSI prevention. One such characteristic that should be
investigated is obesity. This is based on the grounds that the management of obese patients, particularly in
the intensive care unit (ICU), is often physically strenuous and requires additional resources (Humphreys,
2007; Twaij, et al., 2013). Challenges in caring for the obese population, includes turning, mobilizing,
and adequately bathing. Safety during these tasks, for patient and staff, often requires more resources than
many other populations. These resources may not be consistently available, which may impact guideline
adherence (Humphreys, 2007; Twaij, et al., 2013). The hypothesis for this project was that the higher the
patient’s BMI the less adherent nursing staff will be to daily CHG bathing. Patients that are larger in size
may not receive daily CHG bathing because nursing staff may not have additional staff to complete the
bathing and turning processes required.
In clinical practice, age and co morbid conditions are taken into account when planning clinical
management including pharmacotherapy, laboratory interpretation, and therapeutic regimens (Kircher, et
al. 2007; Lea, et al., 2013). The Charlson Co-Morbidity Index was one of the first tools developed to
measure the effects on mortality of co morbid conditions in hospitalized patients (Charlson et al., 1987).
The Charlson Co-Morbidity has been widely used to measure co morbidities and has been extensively
studied in a variety of populations including trauma (de Groot et al., 2003). As increased age and high co
morbid burden are shown to have increased length of stay, ventilator days, and mortality risk following
trauma these characteristics should be evaluated in trauma research, whether clinical, epidemiological, or
quality improvement (Hollis, et al., 2006; Wutzler, et al., 2009;Valderas et al., 2009). The hypothesis for
this project is that as age and Charlson Co-Morbidity Index increases so will guideline adherence. The
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nursing staff will view older patients and patients with a higher co morbid burden as more likely to have
negative outcomes. Therefore they will be more diligent about adhering to guidelines that aim to prevent
CLABSI and poor patient outcomes.
Another important characteristic is quantifying the acuity of a patient such as using the Injury
Severity Score in the trauma population. Among anatomical severity scores, the Injury Severity Score
(ISS), created by Baker et al. in 1974 has been considered for over 20 years to be the gold standard to
classify trauma victims, both blunt and penetrating. Just as injury severity guides clinical management, is
an essential factor investigating guideline adherence it may also aid in practice improvement. An ISS
score of 15 or higher is the nationally accepted criterion for triage of the trauma patient to a Level I
center, as these patients have at least a 10% chance of dying from a single severe injury or multiple severe
injuries (Baker et al., 1974). Due to these mortality implications in conjunction with CLABSI mortality,
the hypothesis is made that as the ISS increases CHG bathing guideline adherence will also increase. In
other words, the sicker the patient the more likely the nursing staff will be to adhere to CLABSI
preventative guidelines and optimize patient outcome.
There are two other important factors that should be considered in CLABSI prevention. First is
the length of time a central line is in place. Research has demonstrated that the longer a central line is in
place the greater the likelihood of developing CLABSIs (Behrenholtz, et al., 2004; Pronovost, et al.
2006). The hypothesis is the longer a patient has a central line the more adherent nursing staff will be to
the CHG bathing guideline because of the known increased infection risk with longer dwelling central
lines. The current Healthcare Infection Control Practices Advisory Committee recommends removing
central venous lines as soon as safely possible to reduce infection and complication risk (Parenti et al.,
1994, Lederle et al., 1992; Pronovost, et al. 2006). The second is the anatomical location of the central
line. The Infectious Disease Society of America (IDSA) and the Centers for Disease Control and
Prevention (CDC) discourage the choice of femoral site for the insertion of central venous catheters due
to increased risk for infection (Marschall et al, 2008; Merrer, et al., 2001; Goetz, et al., 1998; Robinson, et
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al., 1995). Therefore, the hypothesis is that nursing staff will be more compliant with the CHG daily
bathing guideline in patients with a femoral line in order to reduce infection risk.
Increased morbidity, mortality and negative patient outcomes combined with elevated healthcare
cost, CLABSIs warrant considerable preventative efforts. Evaluating preventative efforts through
guideline compliance is key practice improvement and decreasing CLABSI risk. By identifying, which
patient characteristics or factors are associated with low guideline adherence then practice improvement
can be focused, not only the overall importance of compliance but also draw attention to identified
associations of low adherence.
Description of Practice Inquiry Project
This practice inquiry project evaluated adherence to the daily CHG bathing guideline in two 12bed trauma/surgical ICUs at the University of Kentucky Chandler Medical Center, an 875-bed level 1
trauma center located in central Kentucky by conducting a retrospective medical chart review.
Goals and Objectives
The objectives of this project were to (i) evaluate provider adherence to a daily whole body CHG
bathing guideline and (ii) to identify associations between guideline adherence and patient characteristics
such as age, Injury Severity Score, Charlson Comorbidity Index score, BMI along with location of central
line, central line dwell days. Based on these objectives, the primary goal of this project is to utilize results
to inform decisions about need for quality improvement initiative aimed toward the prevention of
CLABSIs.
Methods
Human Subject and Research Approval Procedures:
Following the development of a project proposal and approval from the practice inquiry
committee, approval was obtained from the University of Kentucky Nursing Research Council (Appendix
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A). An expedited proposal was then submitted and subsequently approved by the hospital’s Institutional
Review Board (IRB; Appendix B). Patient consent was waived in compliance with IRB regulations.
Service line directors and ICU nurse managers were informed of the project via hospital email
communication. Approval was obtained from the director of Trauma/Surgical Services (Appendix C).
Study Setting:
The study was conducted in two 12-bed trauma/surgical ICUs at the University of Kentucky
Chandler Medical Center, an 875-bed, American College of Surgeons accredited level 1 trauma center
located in central Kentucky.
Study Design and Selection of Participants:
A retrospective electronic medical chart review was performed. The study population inclusion
criteria was all adult trauma patients, age 18 years and over with the documented presence of a central
line within 24 hours of admission to one of the ICUs, no documented CHG allergy, and admission
between June 2013 and June 2014. The Trauma/Surgical Service Department was utilized to access the
UK HealthCare Trauma Database to obtain a generated report of patient medical record numbers with
correlating Injury Severity Scores that met the sample population inclusion criteria. A total of 154 patients
met the inclusion criteria. This generated report was in the form of an Excel spreadsheet. Using the
random sample software within the Excel program, a simple random sample of 100 medical record
numbers was selected. The master list consisted of the 100 medical records selected, and a study number
was assigned to each individual medical record number. The study numbers were used on all data
collection tool spreadsheets (Appendices D and E) and were kept separate from the master list.
Utilizing this list, a total of 100 patient charts were reviewed and data were collected via
electronic medical records. The data collected included the following: demographics (age, gender, and
ethnicity), mechanism of injury, BMI, anatomical location of central line, and documentation of daily
patient bathing during the presence of a central line. The anatomical location of central line and daily
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bathing documentation includes documentation for each day the patient had a central line, if CHG
solution was used for bathing, the Injury Severity Score, and co-morbid conditions in order to calculate
the Charlson Comorbidity Index score.
Measures:
Guideline adherence for the purpose of this project is defined as documentation of a patient
receiving a CHG bath once within every 24-hour period during the presence of a central line in the
medical chart. In the case of blank documentation a CHG bath was considered not done and adherence
was considered noncompliant. The measures of association are between provider guideline adherence to
patient characteristics including: age, Injury Severity Score, Charlson Comorbidity Index score, location
of central line, central line dwell days, and BMI.
Instruments:
The ISS reflects an anatomic scoring of injury severity and is generally recognized as a tool for
retrospective application only. It is the injury severity score tool used by the University of Kentucky
Trauma Database registrar and reported to regional and national trauma databases. It is calculated by
assigning a severity score defined by the Abbreviated Injury Score (AIS) dictionary to any or all of the six
body regions: head/neck, thorax, abdomen, extremities, external structure, and face. The scores range
from 1 (minor) to 5 (critical—survival uncertain). A score of 6 may be assigned to a region that has an
injury considered not survivable, as defined by the AIS dictionary. After all injuries are identified, scores
are assigned by body region. The scores of the three most severely injured regions are squared and added
together to calculate the ISS, which ranges from 1 to 75. An ISS score of 75 can be obtained any time a
single body region is assigned an AIS of 6. An ISS score of 15 or higher is the nationally accepted
criterion for triage of the trauma patient to a Level I center, as these patients have at least a 10% chance of
dying from a single severe injury or multiple severe injuries (Baker et al., 1974).
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The Charlson Comorbidity Index (Appendix D) predicts the 1-year mortality of a patient who
may have a range of comorbid conditions. The index encompasses 19 medical conditions weighted 1–6,
with total scores ranging from 0–37. Each condition is assigned a score of 1, 2, 3, 4, 5, or 6, depending on
the risk of dying associated with each one. Scores are summed to provide a total score to predict
mortality; the higher the score the higher the 10-year mortality rate (Charlson, Pompei, Ales, &
MacKenzie, 1987). The Charlson Comorbidty Index was derived using a population of medical patients,
and has been shown to be reliable and a valid predictor of mortality in a number of populations, including
hospital inpatients and the critically ill (Charlson et al. 1987, Katz et al., 1996, Poses et al, 1996).
Data Analysis:
Data analysis was performed using SPSS ® version 22.0 (SPSS Inc., Chicago, IL). Data were
analyzed using descriptive and inferential statistics. Spearman rho correlation analysis was conducted to
evaluate the association between guideline adherence and patient characteristics including age, Injury
Severity Score, Charlson Comorbidity Index score, central line dwell days, and BMI. A Kruskal-Wallis
Test was used to analyze association between guideline adherence and anatomical locations of central
line. This study considered values of p < 0.05 to be statistically significant for the analysis.
Results
Sample Characteristics
The demographics of the participants are presented in Table 1. Of the 100 study participants, 61
were male and 39 were female. Their average age was 48.65 years (SD = 18.7), and they had a mean BMI
of 28.6. A normal BMI is 18.5 to 24.9 with below 18.5 being underweight and above 24.9 overweight. In
terms of ethnicity, 93 were Caucasian, 4 were African American, 2 were Hispanic, and 1 was unknown.
There was a total 589 central line days, with average dwell days of 5.9 and range from 1–19 days. The
most frequent central line location was in the subclavian vein (Table 2). Over half of the patients’
diagnoses of trauma had a mechanism of action of motor vehicle accidents (MVA; 52%). This was
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followed by falls (14%), motorcycle accidents (10%), gunshot wounds (8%), pedestrian versus car
accidents (5%), all-terrain vehicle accidents (3%), farm-related accidents (3%), and unknown causes (5%)
(Figure 1). The mean ISS for the sample population was 24.23 (Figure 2). A major trauma (or
polytrauma) is defined as an ISS being greater than 15 (Copes et al., 1988). The mean Charlson
Comorbidity Index score of the sample population was 1.07 (Figure 3).
Guideline Adherence
Analyses showed only 17% of patients received CHG baths each day a central line was present
(Figure 4). Patients received a traditional soap and water bath 96.9% of days and a CHG bath only 60.5%
of days (Figure 5). Guideline adherence per central line location was not significantly different. Internal
jugular locations were washed with CHG 61.3% of days, subclavian locations were washed with CHG
60.7% of days, and femoral locations were washed with CHG 50.7% of days (Figure 6).
Analysis
Spearman rho correlation analysis was conducted to assess if an association between guideline
adherence and patient characteristics existed (Table 3). There was a statistically significant negative
correlation between length of central line days and guideline adherence, with a Spearman rho = -0.48 and
p < 0.0001. However, there was no evidence of correlation between guideline adherence and the
following: ISS (Spearman rho = -0.17; p < 0.091), BMI (Spearman rho = 0.15; p < 0.145), Charlson
Comorbidity Score (Spearman rho = -0.05; p <0.603), or age (Spearman rho =0.13; p <0.117). A KruskalWallis Test revealed no statistically significant difference in guideline adherence across three different
central venous catheter locations (χ² [2, n = 93] = 0.293, p = 0.864);( Table 4).
Discussion
Central line-associated bloodstream infections result in thousands of deaths each year and billions
of dollars in added healthcare costs. Fortunately, these infections are preventable and evidence based
practice guidelines and institutional policies are the foundation of prevention.
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Important risk factors associated with CLABSIs include poor staff adherence to infection prevention
practices during insertion and care for these devices when in place. These infections are considered an
avoidable risk to patient safety, and recommendations have been issued from professional and national
agencies to focus on their prevention (Burke, et al., 2003; Pittet, et al., 2006; Yokoe, et al., 2008).
However, there is concern that healthcare professionals may be inconsistent with adherence to guidelines
or quality improvement interventions. Inherently, this may place the vulnerable patient at risk for device
related infections.
The implementation and use of clinical practice guidelines among nurses is a complex process in
which social and organizational barriers concerning workload, communication, and education play an
important role (Abrahamson, Fox, & Doebbeling, 2012).This project was designed to evaluate adherence
to a CLABSI preventative guideline and to identify practice gaps in daily CHG bathing care delivery by
examining guideline adherence with patient characteristics. The results demonstrated extremely poor
guideline adherences at only 17%. Meaning that out of 100 patients only 17 received a daily CHG bath
during the entire length of central line dwell time. These findings are damaging to CLABSI prevention
efforts because they demonstrate a lack in prevention thus increasing the risk for CLABSIs development.
Of the 589 central line days analyzed, patients’ received a CHG bath 60.5% of the days. However,
patients’ received a traditional soap and water bath 96.9% of the days). As discussed data extraction was
from nursing documentation and must be factored in to any analysis of guideline adherence. Due to the
significant difference in CHG baths document versus soap and water baths it leads to question the
logistics of nursing documentation. Including where within the electronic chartings is CHG bathing
documented. The low rate of compliance may be secondary to the additional steps required for complete
documentation.
A statistically significant, negative correlation between guideline adherence and central line
dwell days was identified. As central line dwell days increased, CHG bathing adherence decreased.
Currently no other research is available to compare if these findings are a pattern. However, research has
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shown that the longer a central line is in place the greater the likelihood of developing CLABSIs
(Behrenholtz, et al., 2004; Pronovost, et al. 2006). Analysis found no other statistically significant
associations between guideline adherence and age, BMI, central line location, ISS, or Charlson
Comorbidity index. These findings are interesting due to the fact that line placement location and length
of dwell time has long been associated with increased risk of infection (Behrenholtz, et al., 2004;
Pronovost, et al. 2006). A lack of association between guideline adherence and central line location is
interesting due to the continued emphasis on femoral line placement being at higher risk for infection
(O’Grady et al., 2011). These findings warrant further investigation into nursing staff knowledge around
CLABSI risk factors.
The lack of association between guideline adherence and Charlson Comorbidity Index may be
attributed to the sample population’s particularly low mean score of 1.07. This indicates that the patients
making up the sample population had very few preexisting conditions and/or comorbidities. The Charlson
Comorbidity Index itself was not developed specifically for trauma patients, which may explain the lack
of significant findings in the current study. However, the median age of the sample population patients
being quite young at 48.65 years, which correlates with trauma being the leading cause of death for
people ages 1-44 in the United States may be another factor of the low Charlson Comorbidity Index
(Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2011).
However, 80% of older adults have one chronic condition, and 50% have at least two. Infectious diseases
and injuries also take a disproportionate toll on older adults (Bell, 2014; Fuchs, et al., 2012). Efforts to
identify strategies to prevent or reduce the risk of disease and injury and to widely apply effective
interventions must be promptly implemented.
An absence of association between guideline adherence and ISS was surprising due to a relatively
high mean ISS. The mean ISS for the sample population was 24.23 and an ISS of 15 or greater qualifies
for triage at a Level I center, as these patients have at minimum a 10% chance of dying from injuries
(Baker et al., 1974). Considering that patients with higher ISS scores have a higher chance of mortality, it
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may be hypothesized that the higher chance of mortality may motivate adherence. The findings of this
project identified a clear need for further quality improvement work in CHG bathing guideline adherence;
such as poor guideline adherence and the finding of a negative correlation between central line dwell days
and guideline adherence. Nurses are central in hospital efforts to improve quality care and their
involvement in future improvement will be vital to its success.
Limitations
The limitations of this project include the small sample size and the retrospective chart review
design, both of which may affect the validity of the study results. The small sample size minimized the
statistical power and thus under powers the strength of the conclusions. Clinical significance could be
looking into documentation practices to make it more likely documentation of CHG baths will be accurate
therefore making the statistics more accurate and reliable. The retrospective design of the study using a
chart review method represents self-reported documentation of tasks completed and thus must be
considered when reviewing results. No real-time observation was conducted; therefore, the data extracted
must be factored into the validity of the study results. The study population included only patients’ in the
Trauma/Surgical Service Line; thus, conclusions cannot be generalized to other areas within the
institution or to other patient populations. Another limitations is that nursing staff patterns were not
examined during this project which have been shown to impact nursing practice and patient outcomes
(Mefford & Alligood, 2011; Kane et al., 2007).
Implications for Practice
The prevention of HAIs, including CLABSIs, requires a multi-disciplinary approach.
However, bedside nurses are in a key position to lead preventative practices and improve
patient outcomes. The current policy at the University of Kentucky Chandler Medical Center is that all
patients over the age of one month with a central line present are to be bathed daily using a CHG solution
(University of Kentucky Hospital, 2013). The results of this study suggest that a substantial quality
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improvement initiative is warranted to improve CHG bathing policy adherence. Armed with this evidence
nurse managers and service line directors should address nursing staff with the low policy adherence.
Should first implement intense educational program aimed at risk factors for CLABSI and nursing
interventions that can impact those outcomes.
Communication between bedside nursing staff and administration should include both facilitators
and barriers of policy adherence. While gaining input, education is also important. Individuals that
understand the purpose and evidence behind change are more likely to adapt and implement a change.
Instituting an educational module on the guideline itself and emphasizing the importance of
documentation is critical. Additionally, routine competencies will be necessary to improve and sustain
guideline adherence. The Trauma/Surgical Service Department has an opportunity to reach out for
support from hospital administration and senior leadership to develop and implement a program targeted
at increasing nursing knowledge and awareness of the guideline policy throughout the enterprise.
Implications for Future Research
Future research should include a more rigorous study design to evaluate guideline adherence and
perceived facilitators and barriers to adherence and include staffing patterns. This project looked at
overall guideline adherence rather than the delivery method of the CHG bath. The current delivery
method of CHG bathing at the University of Kentucky Medical Center involves traditional water basins,
non-medicated cloths and a 4% liquid CHG solution. Investigation of care providers’ CHG bathing
delivery is also warranted to assure proper delivery technique is applied. As CLABSIs and other
healthcare-associated bloodstream infections are becoming increasingly common outside the ICU, CHG
daily bathing guideline adherence should also be examined in non-ICU settings with different patient
populations.
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Conclusion
The development of a CLABSI carries significant health risk and financial burden and requires
the attention of every clinician involved in the management of affected patients. The commitment to
preventing central line associated bloodstream infections gained national momentum with the 100,000
Lives Campaign in 2005 (Berwick, Calkins, McCannon, & Hackbarth, 2006). As pay-for-performance
takes full effect, hospital-acquired infection prevention protocols have been gaining popularity and are
critical to both patient outcomes and the sustainability of organizations. The Centers for Medicare and
Medicaid Services (CMS) has not reimbursed hospitals for the costs of care associated with certain HAIs,
including surgical site infections, CLABSIs, and catheter-associated urinary tract infections, since 2008.
Many organizations have developed and implemented various evidence-based practice (EBP) guidelines
that have not only improved patient outcomes but have saved millions of healthcare dollars. The results of
this study provide evidence that further research is necessary to build on this educational intervention in
order to design, implement, and evaluate programs that are effective and sustainable over time.

64

65

5% Other
3% ATV

3% Farm

5% Ped vs car

8% GSW

52% MVA
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14% FALL
10% MCA
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5% Ped vs car
3% ATV
3% Farm
5% Other

Figure 1: Sample mechanism of action demographics
Note. MVA= Motor Vehicle Accident, MCA =Motorcycle Accident, GSW=Gun Shot Wound,
Ped=Pedestrian, ATV= All-terrain Vehicle
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Distribution of Injury Severity Scores

Figure 2: Distribution of Injury Severity Scores
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Distribution of Charlson
Comorbidity Index Scores

Figure 3: Distribution of Charlson Comorbidity Scores
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Table. 4 Kruskal-Wallis Test

Ranks

Type of line
Percent of total
days had chg
bath

Mean
Rank

N

SC ony

45

46.72

IJ only

39

46.27

9

51.56

Fem only
Total

93

Test Statisticsa,b
Percent of
total days
had chg bath
Chi-Square
df
Asymp.
Sig.

.293
2
.864

a. Kruskal Wallis Test
b. Grouping Variable: Type
of line
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Conclusion
The original “Making Health Care Safer” report examined the prevalence, strategies, and
costs associated with CLABSI prevention, and found that certain practices were associated with
both a decrease in CLABSI risk and reduced cost, whereas others added expense without clear
benefit (Shojania et al., 2001). The efforts made for CLABSI prevention exemplify not only the
complexity of these infections but also the creativity required to stop them. This practice inquiry
practice identifies a simple adjunct strategy for the prevention of CLABSIs. Manuscript one
reviews the literature on daily CHG whole body patient bathing and identifies it to be an effective
adjunct CLABSI prevention technique. National regulatory agencies and professional
organizations support the use of daily CHG bathing during the presence of a central line and is
recommended adjunct therapy as part of a routine CLABSI prevention protocol (O’Grady et al.,
2011; The Society of Healthcare Epidemiology of America, 2014). Daily bathing with CHG
impregnated washcloths is a strategy that is relatively straightforward to implement because it
does not require a substantial change from patient-bathing practices that are currently routine.
Manuscript 2 highlighted a daily CHG bathing protocol using CHG impregnated cloths and
demonstrated its potential cost savings through a cost benefit analysis. Manuscript 3 evaluated
current CHG bathing guideline adherence in two trauma/surgical ICUs and associations between
patient characteristics and factors that may impact adherence. The findings of this project
showed significantly low guideline adherence. Further work is warranted to increase CHG daily
bathing guideline compliance for CLABSI prevention.
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Appendix C: Approval letter from Director of Trauma/Surgical Services
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Appendix D: Charlson Comorbidity Index

Charlson Comorbidity Index
Pt. ID # _____________________
Does the Patient have?
1.Myocardial infarction

No

Yes

Score 1

2.Congestive Heart Failure

No

Yes

Score 1

3.Peripheral Vascular disease

No

Yes

Score 1

4.Cerebrovascular Disease

No

Yes

Score 1

5.Dementia

No

Yes

Score 1

6.Chronic Pulmonary disease

No

Yes

Score 1

7.Connective tissue disease

No

Yes

Score 1

8.Stomach or Peptic ulcer disease

No

Yes

Score 1

9.Hemiplegia

No

Yes

Score 2

10.Diabetes

No

Yes

Score 1

11.If yes, has the diabetes caused any organ damage

No

Yes

Score 2

12.Moderate to severe renal disease

No

Yes

Score 2

13.Mild Liver disease

No

Yes

Score 1

14.Cirrhosis or serious liver disease

No

Yes

Score 3

15.AIDS

No

Yes

Score 6

16.Leukemia

No

Yes

Score 2

17.Lymphoma

No

Yes

Score 2

18. Cancer other than skin cancer, leukemia, or lymphoma with
the last 5 years?

No

Yes

Score 2

19. If yes, has the cancer spread or metastasized to other parts
of the body?

No

Yes

Score 6

Total Score =
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Appendix E: Data Collection Tool

Data Collection Tool
Patient Study Number # __________________
Sex: Male or Female
Age: _______
Race: Caucasian, African American, Hispanic, Other
Mechanism of Injury:__________________________
Injury Severity Score: _______
Charlson Comorbidity Index: __________
Body Mass Index (BMI): ______
Day of
central
line

Location of Central line
IJ =1
SC=2
Femoral=3

Daily bath
Received
Yes=1
No=2
Blank=3

CHG Used for Bathing
Yes=1
No=2
Blank=3

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Key: CHG= Chlorhexidine Gluconate, IJ= Intrajugular, SC=Subclavian
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